InspireMD (NSPR) Return on Capital Employed (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,840.00 |
| Sep 30, 2025 | 1,301.00 |
| Jun 30, 2025 | -2,718.00 |
| Mar 31, 2025 | -1,403.00 |
| Dec 31, 2024 | 4,900.00 |
| Sep 30, 2024 | -61.00 |
| Jun 30, 2024 | -426.00 |
| Mar 31, 2024 | -1,112.00 |
| Dec 31, 2023 | -638.00 |
| Sep 30, 2023 | 1,722.00 |
| Jun 30, 2023 | 4,371.00 |
| Mar 31, 2023 | -1,602.00 |
| Dec 31, 2022 | -2,097.00 |
| Sep 30, 2022 | -839.00 |
| Jun 30, 2022 | -1,147.00 |
| Mar 31, 2022 | -710.00 |
| Dec 31, 2021 | -440.00 |
| Sep 30, 2021 | -667.00 |
| Jun 30, 2021 | 957.00 |
| Mar 31, 2021 | 4,145.00 |
| Dec 31, 2020 | -1,492.00 |
| Sep 30, 2020 | 3,132.00 |
| Jun 30, 2020 | 4,809.00 |
| Mar 31, 2020 | -1,586.00 |
| Dec 31, 2019 | -1,150.00 |
| Sep 30, 2019 | 590.00 |
| Jun 30, 2019 | -1,999.00 |
| Mar 31, 2019 | -2,827.00 |
| Dec 31, 2018 | -122.00 |
| Sep 30, 2018 | 4,454.00 |
| Jun 30, 2018 | 8,999.00 |
| Mar 31, 2018 | -857.00 |
| Dec 31, 2017 | -3,152.00 |
| Sep 30, 2017 | -4,776.00 |
| Jun 30, 2017 | -1,600.00 |
| Mar 31, 2017 | 2,011.00 |
| Dec 31, 2016 | 26,208.00 |
| Sep 30, 2013 | 3,093.00 |
| Jun 30, 2013 | -807,970.00 |
| Mar 31, 2013 | 856,387.00 |
| Dec 31, 2012 | -47,176.00 |
| Mar 31, 2012 | -8,222.00 |
| Dec 31, 2011 | -9,327.00 |